Literature DB >> 26668611

Comparative study of HPV16 integration in cervical lesions between ethnicities with high and low rates of infection with high-risk HPV and the correlation between integration rate and cervical neoplasia.

Lili Han1, Tuerxunayi Maimaitiming2, Sulaiya Husaiyin2, Lin Wang2, Kunduozi Wusainahong2, Chunhua Ma2, Mayinuer Niyazi2.   

Abstract

The etiology of a high incidence of cervical cancer in populations with a low human papillomavirus (HPV) infection rate is unclear. The current study aimed to investigate the role of HPV16 DNA integration in cervical lesions in women of Han and Uygur ethnicity and to explore the association between viral integration and a high cervical cancer morbidity with a low HPV infection rate. DNA was extracted from the biopsy specimens of cervical lesions of 379 patients of Uygur ethnicity and 464 patients of Han ethnicity, and multiple quantitative polymerase chain reaction (qPCR) assays were performed to determine the copy numbers of the HPV16 E2 and E6 genes. The copy number of the HPV16 DNA was evaluated according to the E2/E6 ratio. Among these cases, 122 Uygur and 121 Han specimens were found to be HPV16 positive. In the two populations, the percentage of cases with HPV16 integration (the sum of integrated-type infection only or a mixture of free-and integrated-type infection) increased with the grade of the cervical lesions (P<0.001). Within groups with the same cervical lesion grade, no significant differences in HPV16 integration were found between women of Uygur and Han ethnicity (rank sum test, P>0.05). No significant differences in the distribution of the HPV16 integration rate according to lesion grade were found in either population (P>0.05). When the two subpopulations were considered as one sample population, the integration rate significantly increased with lesion grade (P=0.02). These results indicate that the integration rate of HPV16 E2 may serve as a molecular biological marker for the development of cervical lesions.

Entities:  

Keywords:  E2 integration; HPV16; Uygur; cervical lesion; multiple quantitative polymerase chain reaction

Year:  2015        PMID: 26668611      PMCID: PMC4665317          DOI: 10.3892/etm.2015.2740

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  17 in total

1.  Physical status and expression of HPV genes in cervical cancers.

Authors:  J S Park; E S Hwang; S N Park; H K Ahn; S J Um; C J Kim; S J Kim; S E Namkoong
Journal:  Gynecol Oncol       Date:  1997-04       Impact factor: 5.482

Review 2.  Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment.

Authors:  T L Cornelison
Journal:  Curr Opin Oncol       Date:  2000-09       Impact factor: 3.645

3.  Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.

Authors:  Hugo Arias-Pulido; Cheri L Peyton; Nancy E Joste; Hernan Vargas; Cosette M Wheeler
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  E2 sequence variations of HPV 16 among patients with cervical neoplasia seen in the Indian subcontinent.

Authors:  Narayanan Sathish; Priya Abraham; Abraham Peedicayil; Gopalan Sridharan; R V Shaji; George Chandy
Journal:  Gynecol Oncol       Date:  2004-11       Impact factor: 5.482

5.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

6.  Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions.

Authors:  Monica Cricca; Simona Venturoli; Elisa Leo; Silvano Costa; Monica Musiani; Marialuisa Zerbini
Journal:  J Virol Methods       Date:  2009-01-31       Impact factor: 2.014

7.  Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis.

Authors:  L-W Huang; S-L Chao; B-H Lee
Journal:  J Clin Pathol       Date:  2007-12-12       Impact factor: 3.411

8.  The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.

Authors:  Wei Li; Wei Wang; Mani Si; Linfei Han; Qinglei Gao; Aiyue Luo; Yan Li; Yunping Lu; Shixuan Wang; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-14       Impact factor: 4.553

9.  Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China.

Authors:  Jing Li; Lian-Kun Li; Jun-Fei Ma; Li-Hui Wei; Mayinuer Niyazi; Chang-Qing Li; Ai-Di Xu; Jian-Bin Wang; Hao Liang; Jerome Belinson; You-Lin Qiao
Journal:  Vaccine       Date:  2009-01-09       Impact factor: 3.641

10.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

View more
  6 in total

1.  Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.

Authors:  J R Montealegre; E C Peckham-Gregory; D Marquez-Do; L Dillon; M Guillaud; K Adler-Storthz; M Follen; M E Scheurer
Journal:  Gynecol Oncol       Date:  2017-12-21       Impact factor: 5.482

2.  Accurate Detection of HPV Integration Sites in Cervical Cancer Samples Using the Nanopore MinION Sequencer Without Error Correction.

Authors:  Wenjuan Yang; Ying Liu; Ruyi Dong; Jia Liu; Jidong Lang; Jialiang Yang; Weiwei Wang; Jingjing Li; Bo Meng; Geng Tian
Journal:  Front Genet       Date:  2020-06-26       Impact factor: 4.599

3.  CRISPR-typing PCR (ctPCR), a new Cas9-based DNA detection method.

Authors:  Qiao Wang; Beibei Zhang; Xinhui Xu; Feifei Long; Jinke Wang
Journal:  Sci Rep       Date:  2018-09-20       Impact factor: 4.379

4.  Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology.

Authors:  Andriniaina Andy Nkili-Meyong; Pamela Moussavou-Boundzanga; Ingrid Labouba; Ismaël Hervé Koumakpayi; Emmanuelle Jeannot; Stéphane Descorps-Declère; Xavier Sastre-Garau; Eric M Leroy; Ernest Belembaogo; Nicolas Berthet
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

5.  HPV16 E6 regulates the proliferation, invasion, and apoptosis of cervical cancer cells by downregulating miR-504.

Authors:  Lina Zhang; Baozhen Xu; Yiqing Lai; Yangyang Sun; Xian Qiang; Xiaoli Zhou; Ting Wang
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

6.  Human Papillomavirus Detection by Whole-Genome Next-Generation Sequencing: Importance of Validation and Quality Assurance Procedures.

Authors:  Laila Sara Arroyo Mühr; Daniel Guerendiain; Kate Cuschieri; Karin Sundström
Journal:  Viruses       Date:  2021-07-08       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.